← back to search

Stephanie Padberg

Charité - Universitätsmedizin Berlin · DE
Area of research
Public Health, Environmental and Occupational Health · Obstetrics and Gynecology
Research interest
Research interests include Pregnancy and Medication Impact, Pregnancy and preeclampsia studies, Breastfeeding Practices and Influences, and Maternal Mental Health During Pregnancy and Postpartum.
h-index
14
citations
563
works
44
NIH funding
primary concept
email

Recent publications

Impact of maternal first trimester treatment regimen on the outcome of valproate exposed pregnancies: an observational Embryotox cohort study
Scientific Reports 2024cited by 8position: middledoi
Landmarking for Left‐Truncated Competing Risk Data
Biometrical Journal 2024cited by 1position: middledoi
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
BMC Pregnancy and Childbirth 2022cited by 38position: middledoi
First trimester naproxen exposure and outcome of pregnancy – A German case series
Reproductive Toxicology 2021cited by 12position: middledoi
Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third‐trimester paracetamol use: evaluation of the German Embryotox cohort
BJOG An International Journal of Obstetrics & Gynaecology 2019cited by 28position: middledoi
Pregnancy outcome after first-trimester exposure to fosfomycin for the treatment of urinary tract infection: an observational cohort study
Infection 2019cited by 17position: lastdoi
Multistate methodology improves risk assessment under time‐varying drug intake—a new view on pregnancy outcomes following coumarin exposure
Pharmacoepidemiology and Drug Safety 2019cited by 14position: middledoi
No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort
Reproductive Toxicology 2018cited by 36position: middledoi
Safety of diclofenac use during early pregnancy: A prospective observational cohort study
Reproductive Toxicology 2018cited by 23position: firstdoi
Exposure to cox-2 inhibitors (coxibs) during the first trimester and pregnancy outcome: a prospective observational cohort study
European Journal of Clinical Pharmacology 2017cited by 21position: middledoi
Metamizole use during first trimester—A prospective observational cohort study on pregnancy outcome
Pharmacoepidemiology and Drug Safety 2017cited by 18position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Katarina Dathe · Humboldt-Universität zu Berlin8 papers (2017–2024) · 7 papers (2017–2019)Stefanie Hultzsch · Humboldt-Universität zu Berlin7 papers (2017–2022)Anne‐Katrin Fietz · Zimmer Biomet (Netherlands)6 papers (2017–2024)Katja Meixner · Humboldt-Universität zu Berlin6 papers (2017–2019)Christof Schaefer · Humboldt-Universität zu Berlin6 papers (2017–2024)Evelin Beck · Humboldt-Universität zu Berlin5 papers (2017–2024)Christof Schaefer · Humboldt-Universität zu Berlin4 papers (2017–2019) · 3 papers (2019–2024)Tatjana Tissen‐Diabaté · Charité - Universitätsmedizin Berlin3 papers (2017–2018)Regina Stegherr · Humboldt-Universität zu Berlin2 papers (2019–2024) · 2 papers (2019–2024) · 1 papers (2024–2024)Verena Linsenmeier · Humboldt-Universität zu Berlin1 papers (2018–2018)Luisa-Maria Köhler · Humboldt-Universität zu Berlin1 papers (2017–2017)Marlies Onken · Humboldt-Universität zu Berlin1 papers (2024–2024)J Frank · Momentive (United States)1 papers (2019–2019)Johanna Frank · Humboldt-Universität zu Berlin1 papers (2022–2022) · 1 papers (2021–2021)Lucas William Pritchard · Humboldt-Universität zu Berlin1 papers (2018–2018)